EUVIMEDEUVIMED entdecken
Open Access

Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India

Pukhraj Rishi, Ashutosh Agarwal, Pritam Chatterjee, Tarun Sharma, Minal Sharma, Munusamy Saravanan, R Ravikumar

Ocular Oncology and Pathology · 2020 · 6 (1) · 66-73

DOI: 10.1159/000500010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 04.06.2019. Verfasst von Pukhraj Rishi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralya, Chennai, India. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are limited reports of intra-arterial chemotherapy (IAC) for retinoblastoma (RB) from developing world.

Objectives

In this study, we report our 4-year experience of IAC for RB from India.

Methods

Retrospective, interventional case series. Primary outcome measures included tumor regression, vitreous seeds and subretinal seeds control, and globe salvage. Secondary outcome measures were best-corrected visual acuity and treatment complications.

Results

Fifteen eyes underwent 53 IAC procedures over mean 28.6 ± 13.8 months (range 10–51 months). IAC was employed as primary (n = 6) or secondary (n = 9) chemotherapy. Following IAC, complete regression of main tumor was seen in 7 eyes (47%) and partial regression in 3 (20%) eyes. Enucleation was done in 5(33%) eyes. Globe salvage rates were achieved in 1 eye (100%) in group B, 2 eyes (67%) in group C (n = 3), 6 eyes (67%) in group D (n = 9), and 1 eye (50%) in group E (n = 2). Following IAC, Kaplan-Meier survival curve showed 93% globe survival rate at 1 year, 76% at 2 years, and 66% at 3, and 4 years.

Conclusion

IAC has enhanced globe salvage rates in eyes with RB. Multicenter studies with longer follow-up are necessary to better understand outcomes in the long term.

Schlagwörter

Stichwörter der Autor:innen

EyeIndiaIntra‑arterial chemotherapyRetinoblastomaTumor

Autor:innen und Institutionen

  • Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralya, Chennai, India.
  • Apollo Institute of Interventional Radiology, Apollo Hospital, Chennai, India.

Zitieren

APA

Rishi, P., Agarwal, A., Chatterjee, P., Sharma, T., Sharma, M., Saravanan, M., & Ravikumar, R. (2020). Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India. Ocular Oncology and Pathology, 6(1), 66-73. https://doi.org/10.1159/000500010

Vancouver

Rishi P, Agarwal A, Chatterjee P, Sharma T, Sharma M, Saravanan M, et al. Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India. Ocular Oncology and Pathology. 2020;6(1):66-73. doi:10.1159/000500010

BibTeX
@article{Rishi2020,
  author = {Rishi, Pukhraj and Agarwal, Ashutosh and Chatterjee, Pritam and Sharma, Tarun and Sharma, Minal and Saravanan, Munusamy and Ravikumar, R},
  title = {Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India},
  journal = {Ocular Oncology and Pathology},
  year = {2020},
  volume = {6},
  number = {1},
  pages = {66--73},
  doi = {10.1159/000500010}
}
Kostenlos starten →